Akcea Therapeutics (AKCA) Tops Q3 EPS by 7c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St futures muted as higher oil prices temper risk appetite after S&P record close
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Reddit to join S&P 500 index on Aug. 18, shares leap
- Should you chase this mini rally in gold? Citi weighs in
Akcea Therapeutics, Inc. (AKCA) PT Raised to $47 at BMO Capital
November 6, 2018 3:52 AM ESTBMO Capital analyst Do Kim raised the price target on Akcea Therapeutics, Inc. (NASDAQ: AKCA) to $47.00 (from $42.00) while maintaining a Outperform rating.
... More